How the drug services industry found itself prepared for a pandemic
C&EN, 26 September 2021
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
C&EN, 26 September 2021
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Hovione is closer to its customers with a new website in Mandarin
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.